Industrialization of "antimicrobial peptide series drugs" of Kunming Institute of zoology, Chinese Academy of Sciences
-
Last Update: 2010-05-01
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Beijing, Kunming, May 1 (reporter Yang Yang, Zhang Gangqiang) in order to promote the transfer and transformation of scientific and technological achievements, so that scientific and technological achievements can better serve the national and local economy, Kunming Institute of zoology, Chinese Academy of Sciences, biological Industrialization Center was established here today, and signed a cooperation agreement with the first three enterprises According to Dr Lai Ren, director of the Industrialization Center, in the next ten years, the Institute will increase the industrialization of scientific and technological achievements, give full play to its disciplinary advantages, and take biomedicine, efficacy evaluation, drug safety evaluation and modern agricultural platform construction as the current industrialization focus The newly established biological Industrialization Center will take an industrial discipline layout, strengthen the construction of Key Laboratory of animal model and human disease mechanism in Yunnan Province, and lay out the discipline of animal and poultry molecular breeding according to the needs of the development of Yunnan pharmaceutical industry and animal husbandry Lai Ren said that the "national Kunming high-level biosafety primate experimental center", "Kunming National biological industry base experimental animal center" and "regional center of biodiversity large instruments" which have been completed by the Institute will be an important platform for industrialization implementation It is understood that due to the fruitful scientific research results and strong scientific research force of Kunming Institute of zoology, Chinese Academy of Sciences, many domestic and foreign enterprises expect to cooperate with the Institute After preliminary investigation and negotiation, the newly established biological Industrialization Center reached cooperation agreements with three domestic enterprises in the first batch One will use the Institute's advanced livestock and poultry gene analysis technology to provide Tibetan mastiff gene identification standards, cultivate Tibetan mastiff strains and large-scale breeding in line with international famous dog standards Another is to industrialize the new anti infective drug "antimicrobial peptide series drugs" At present, the Institute has established a Chinese antimicrobial peptide molecular resource library, identified more than 500 antimicrobial peptide molecules, and screened more than 10 antimicrobial peptide candidate drugs with potential for anti infective drug development The Institute will work with relevant enterprises to develop "antimicrobial peptide" drugs The last one is to use the primate resources in Yunnan Province and the long-term knowledge and technology accumulation of primates in the area, establish GLP center, efficacy evaluation center and primate pharmacokinetic Laboratory for primate drug safety evaluation, so as to enrich the connotation of national biological industry base, enhance its incubation capacity for biomedical development, and promote the health of Yunnan Province Build a practical and effective Incubation Platform for the development of physical medicine industry It is reported that Kunming Institute of zoology, Chinese Academy of Sciences, is a specialized institution engaged in zoological research Based on the rich biological resources in Southwest China and Southeast Asia, the Institute focuses on three major development fields: evolutionary genetics and development, utilization and protection of biodiversity resources, biology of major disease mechanism and primate model, and cooperates with each other to carry out basic and strategic development And forward-looking scientific and technological innovation activities (end)
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.